Forero-Torres, Andres;
Moskowitz, Craig;
Advani, Ranjana H.;
Shah, Bijal D.;
Kostic, Ana;
Albertson, Tina M.;
Sandalic, Larissa;
Zhao, Baiteng;
Fanale, Michelle A.
Interim analysis of a phase 1, open-label, dose-escalation study of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL)
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Interim analysis of a phase 1, open-label, dose-escalation study of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL)
Contributor:
Forero-Torres, Andres;
Moskowitz, Craig;
Advani, Ranjana H.;
Shah, Bijal D.;
Kostic, Ana;
Albertson, Tina M.;
Sandalic, Larissa;
Zhao, Baiteng;
Fanale, Michelle A.
Published:
American Society of Clinical Oncology (ASCO), 2014
Published in:
Journal of Clinical Oncology, 32 (2014) 15_suppl, Seite 8505-8505